Monoclonal Antibody for Patients with Covid-19. Reply
Research output: Contribution to journal › Comment/debate › Research › peer-review
Standard
Monoclonal Antibody for Patients with Covid-19. Reply. / Lundgren, Jens D.; Lane, H. Clifford; Neaton, James D.
In: The New England Journal of Medicine, Vol. 384, No. 12, 25.03.2021, p. 1171.Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Lundgren, JD, Lane, HC & Neaton, JD 2021, 'Monoclonal Antibody for Patients with Covid-19. Reply', The New England Journal of Medicine, vol. 384, no. 12, pp. 1171. https://doi.org/10.1056/NEJMc2100221
APA
Lundgren, J. D., Lane, H. C., & Neaton, J. D. (2021). Monoclonal Antibody for Patients with Covid-19. Reply. The New England Journal of Medicine, 384(12), 1171. https://doi.org/10.1056/NEJMc2100221
Vancouver
Lundgren JD, Lane HC, Neaton JD. Monoclonal Antibody for Patients with Covid-19. Reply. The New England Journal of Medicine. 2021 Mar 25;384(12):1171. https://doi.org/10.1056/NEJMc2100221
Author
Bibtex
@article{0c408d451ce14a5cb1f1363b15ec129d,
title = "Monoclonal Antibody for Patients with Covid-19. Reply",
author = "Lundgren, {Jens D.} and Lane, {H. Clifford} and Neaton, {James D.}",
year = "2021",
month = mar,
day = "25",
doi = "10.1056/NEJMc2100221",
language = "English",
volume = "384",
pages = "1171",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "12",
}
RIS
TY - JOUR
T1 - Monoclonal Antibody for Patients with Covid-19. Reply
AU - Lundgren, Jens D.
AU - Lane, H. Clifford
AU - Neaton, James D.
PY - 2021/3/25
Y1 - 2021/3/25
U2 - 10.1056/NEJMc2100221
DO - 10.1056/NEJMc2100221
M3 - Comment/debate
C2 - 33534968
AN - SCOPUS:85103606479
VL - 384
SP - 1171
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 12
ER -
ID: 286417900